NEXT Investor Relations
A prospectus dated 1 March 2019 (the “Prospectus”) prepared in connection with the Subsequent Offering is, subject to regulatory restrictions in certain jurisdictions, available at:
Following the completion of the Subsequent Offering, and assuming full subscription, the number of shares outstanding in NEXT will increase by 3,500,000 shares to 42,930,575 shares, each with a nominal value of NOK 1.00, resulting in a total share capital of NOK 42,930,575.
The timetable below provides certain key dates for the Subsequent Offering:
Subscription Period commences:
Monday 4 March 2019
Subscription Period ends:
Monday 11 March 2019 at 16:30 hours (CET)
Allocation of the Offer Shares and distribution of allocation letters:
Expected on or about 12 March 2019
Payment date: 15 March 2019
Delivery of the Offer Shares and listing and commencement of trading in the Offer Shares on Oslo Børs: Expected on or about 20 March 2019
For further details on the terms of the Subsequent Offering, please see the Prospectus.
NEXT Biometrics (NEXT) is listed on the Oslo Børs/Stock Exchange. (from 17.12.2015)
An extraordinary general meeting of NEXT Biometrics Group ASA, was held Friday 15 February 2019 at: Advokatfirmaet Thommessen, Haakon VIIs gate 10, 0161 Oslo. More information here.
Share Performance and share price from the Oslo Stock Exchange. The Company’s objective is to ensure that financial markets have sufficient information about the company to be certain that pricing reflects underlying values. NEXT Biometrics ASA arranges regular presentations, in addition to holding meetings with investors and analysts. Important events affecting the Company are reported immediately.
Oslo Stock Exchange announcements
NEXT Biometrics Group ASA will strive to pursue a professional, transparent, and active dialogue with investors and analysts. The company is committed to disclose and share relevant information in a timely, reliable, and accurate manner with all financial stakeholders in accordance with relevant legal requirements and sound principles of corporate governance. The objective is to ensure equal treatment of all stakeholders and fair valuation of the NEXT Biometrics share.
The analysts listed below follow NEXT Biometrics ASA. Please note that any opinions, estimates, or forecasts regarding NEXT Biometrics ASA performance made by these analysts are theirs alone and not those of NEXT Biometrics ASA or its management. NEXT Biometrics ASA does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.
| Company | Analyst | Tel: | |
|---|---|---|---|
| Carnegie ASA | Hans Rettedal Christiansen | +47 22009321 | hans.christiansen@carnegie.no |
| Pareto Securities AS | Fredrik Steinslien | +47 24132154 | fs@paretosec.com |
| DNB ASA | Christoffer W. Bjørnsen | +47 24169143 | christoffer.wang.bjornsen@dnb.no |
About the NEXT Biometrics share:
About the NEXT Biometrics share:
Name: NEXT Biometrics Group ASA
Ticker: NEXT
Instrument ID: 1301145
ISIN: NO0010629108
Liquidity segment: MATCH
Instrument Type: Share (SH)
Country of register: NO – NORWAY
Trading Currency: NOK
Exchange Market Size (EMS): 100
Face value: NOK 1,00
Number of shares: 39,430,575
Share registrar:
NEXT Biometrics Group ASA is registered with the Norwegian Register of Business Enterprises as a public limited liability company under registration number NO 982 904 420 MVA and is governed by Norwegian law.
The Company’s registrar is:
DnB NOR Verdipapirservice
Kirkegaten 18
P.O. Box 1172 Sentrum
N-0107 Oslo
Tel: +47 815 00 590
NEXT Biometrics Group ASA is registered with the Norwegian Register of Business Enterprises as a public limited liability company under registration number NO 982 904 420 MVA.The Company is a Norwegian public limited liability company and is governed by Norwegian law.
